Mangalam Drugs and Organics reports standalone net profit of Rs 2.68 crore in the June 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.68 crore in the quarter ended June 2024 as against net loss of Rs 9.54 crore during the previous quarter ended June 2023. Sales declined 12.08% to Rs 76.49 crore in the quarter ended June 2024 as against Rs 87.00 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	76.49	87.00	-12
OPM %	10.69	-4.00	-
PBDT	4.45	-6.87	LP
PBT	0.58	-10.29	LP
NP	2.68	-9.54	LP